Movatterモバイル変換
[0]
ホーム
URL:
画像なし
夜間モード
Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Community portal
Project chat
Create a new Item
Recent changes
Random Item
Query Service
Nearby
Help
Special pages
Lexicographical data
Create a new Lexeme
Recent changes
Random Lexeme
Search
Search
English
Appearance
Donate
Create account
Log in
Personal tools
Donate
Create account
Log in
terazosin
(Q280786)
Item
Discussion
English
Read
View history
Tools
Tools
move to sidebar
hide
Actions
Read
View history
General
What links here
Related changes
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Concept URI
Print/export
Create a book
Download as PDF
Printable version
In other projects
Appearance
move to sidebar
hide
From Wikidata
Antihypertensive medication
ABBOTT-45975
Hytrin®
Terazosine
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine
Térazosine
Terazosina
Terazosinum
Terazosin
edit
Language
Label
Description
Also known as
default for all languages
No label defined
–
English
terazosin
Antihypertensive medication
ABBOTT-45975
Hytrin®
Terazosine
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine
Térazosine
Terazosina
Terazosinum
Terazosin
Statements
instance of
type of chemical entity
0 references
subclass of
chemical compound
0 references
has use
medication
0 references
chemical structure
Terazosin.svg
512 × 289; 8 KB
0 references
chemical formula
C₁₉H₂₅N₅O₄
1 reference
stated in
PubChem
PubChem CID
5401
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
canonical SMILES
COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
1 reference
stated in
PubChem
PubChem CID
5401
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
defined daily dose
5
milligram
route of administration
oral administration
1 reference
reference URL
https://www.whocc.no/atc_ddd_index/?code=G04CA03
World Health Organisation international non-proprietary name
terazosin
(English)
1 reference
stated in
ChEBI
ChEBI ID
9445
language of work or name
English
title
terazosin
(English)
retrieved
3 October 2016
medical condition treated
urinary retention
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148025
language of work or name
English
retrieved
13 December 2016
prostatic hypertrophy
2 references
stated in
NDF-RT
NDF-RT ID
N0000148025
language of work or name
English
retrieved
13 December 2016
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
arterial hypertension
2 references
stated in
NDF-RT
NDF-RT ID
N0000148025
language of work or name
English
retrieved
13 December 2016
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
prostatic adenoma
start time
10 February 2000
approved by
United States Food and Drug Administration
1 reference
stated in
Inxight: Drugs Database
retrieved
2 November 2018
reference URL
https://drugs.ncats.io/drug/8L5014XET7
http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75140_Terazosin%20Hydrochloride_prntlbl.pdf
arterial hypertension
start time
11 February 2000
approved by
United States Food and Drug Administration
1 reference
stated in
Inxight: Drugs Database
retrieved
2 November 2018
reference URL
https://drugs.ncats.io/drug/8L5014XET7
http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75140_Terazosin%20Hydrochloride_prntlbl.pdf
significant drug interaction
verapamil
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
avanafil
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
(RS)-metoprolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
vardenafil
side effect
hypotension
1 reference
sourcing circumstances
established
stated in
A reference set of clinically relevant adverse drug-drug interactions
nadolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
atenolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
nebivolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
sildenafil
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
acebutolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
betaxolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
tadalafil
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
bisoprolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
pindolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
carvedilol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
propranolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
sotalol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
labetalol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
celiprolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
levobunolol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
physically interacts with
Adrenoceptor alpha 1A
subject has role
antagonist
1 reference
stated in
IUPHAR/BPS Guide to PHARMACOLOGY
Guide to Pharmacology Ligand ID
7302
language of work or name
English
retrieved
17 August 2016
Adrenoceptor alpha 1B
subject has role
antagonist
1 reference
stated in
IUPHAR/BPS Guide to PHARMACOLOGY
Guide to Pharmacology Ligand ID
7302
language of work or name
English
retrieved
17 August 2016
Adrenoceptor alpha 1D
subject has role
antagonist
1 reference
stated in
IUPHAR/BPS Guide to PHARMACOLOGY
Guide to Pharmacology Ligand ID
7302
language of work or name
English
retrieved
17 August 2016
LiverTox likelihood score
LiverTox toxicity likelihood category E
1 reference
stated in
LiverTox
retrieved
8 April 2021
reference URL
https://www.ncbi.nlm.nih.gov/books/n/livertox/Terazosin
last update
8 January 2018
mass
387.191
dalton
1 reference
stated in
PubChem
PubChem CID
5401
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
subject has role
alpha blocker
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148025
retrieved
5 March 2018
adrenergic alpha-1 receptor antagonists
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
C041226
retrieved
15 March 2018
urological agents
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
C041226
retrieved
15 March 2018
Commons category
Terazosin
0 references
Identifiers
InChI
InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)
1 reference
stated in
PubChem
PubChem CID
5401
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
InChIKey
VCKUSRYTPJJLNI-UHFFFAOYSA-N
2 references
stated in
PubChem
PubChem CID
5401
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
stated in
ChEBI release 2020-09-01
CAS Registry Number
63590-64-7
2 references
stated in
Global Substance Registration System
UNII
8L5014XET7
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
InChIKey
VCKUSRYTPJJLNI-UHFFFAOYSA-N
stated in
CAS Common Chemistry
retrieved
9 April 2021
reference URL
https://commonchemistry.cas.org/detail?cas_rn=63590-64-7
ChemSpider ID
5208
1 reference
stated in
ChemSpider
ChemSpider ID
5208
language of work or name
English
title
Terazosin
(English)
retrieved
18 November 2016
PubChem CID
5401
2 references
stated in
PubChem
PubChem CID
5401
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
matched by identifier from
InChIKey
InChIKey
VCKUSRYTPJJLNI-UHFFFAOYSA-N
Reaxys registry number
719452
1 reference
stated in
ChEBI
ChEBI ID
9445
language of work or name
English
title
terazosin
(English)
retrieved
3 October 2016
ChEBI ID
9445
mapping relation type
exact match
2 references
stated in
ChEMBL
ChEMBL ID
CHEMBL611
language of work or name
English
title
TERAZOSIN
(English)
retrieved
18 November 2016
matched by identifier from
International Chemical Identifier
InChI
InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)
ChEMBL ID
CHEMBL611
1 reference
stated in
ChEMBL
ChEMBL ID
CHEMBL611
language of work or name
English
title
TERAZOSIN
(English)
retrieved
18 November 2016
SureChEMBL ID
6528
2 references
based on heuristic
inferred from InChIKey
matched by identifier from
InChIKey
InChIKey
VCKUSRYTPJJLNI-UHFFFAOYSA-N
UniChem compound ID
95563
1 reference
stated in
UniChem
DSSTox substance ID
DTXSID3023639
2 references
stated in
Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
matched by identifier from
InChIKey
InChIKey
VCKUSRYTPJJLNI-UHFFFAOYSA-N
DSSTOX compound identifier
DTXCID003639
0 references
LiverTox ID
Terazosin
0 references
EC number
613-265-8
1 reference
stated in
ECHA Substance Infocard database
ECHA Substance Infocard ID
100.118.191
retrieved
27 December 2018
title
6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine
(English)
quotation
CAS no.: 63590-64-7
(English)
ECHA Substance Infocard ID
100.118.191
1 reference
stated in
ECHA Substance Infocard database
ECHA Substance Infocard ID
100.118.191
retrieved
27 December 2018
title
6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine
(English)
quotation
CAS no.: 63590-64-7
(English)
ATC code
G04CA03
1 reference
stated in
DrugBank
DrugBank ID
DB01162
language of work or name
English
title
Terazosin
(English)
publication date
17 November 2015
Guide to Pharmacology Ligand ID
7302
1 reference
stated in
IUPHAR/BPS Guide to PHARMACOLOGY
Guide to Pharmacology Ligand ID
7302
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
MeSH descriptor ID
C041226
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
C041226
retrieved
14 March 2018
RxNorm CUI
37798
1 reference
stated in
Global Substance Registration System
UNII
8L5014XET7
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
DrugBank ID
DB01162
1 reference
matched by identifier from
InChIKey
InChIKey
VCKUSRYTPJJLNI-UHFFFAOYSA-N
Human Metabolome Database ID
HMDB0015293
2 references
based on heuristic
inferred from InChIKey
matched by identifier from
InChIKey
InChIKey
VCKUSRYTPJJLNI-UHFFFAOYSA-N
UNII
8L5014XET7
2 references
stated in
Global Substance Registration System
UNII
8L5014XET7
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
matched by identifier from
InChIKey
InChIKey
VCKUSRYTPJJLNI-UHFFFAOYSA-N
MedlinePlus drug identifier
a693046
0 references
NDF-RT ID
N0000148025
1 reference
stated in
Global Substance Registration System
UNII
8L5014XET7
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
Probes And Drugs ID
PD002848
0 references
DrugCentral ID
3584
1 reference
stated in
UniChem
KEGG ID
C07127
1 reference
stated in
ChEBI
ChEBI ID
9445
language of work or name
English
title
terazosin
(English)
retrieved
3 October 2016
D08569
1 reference
stated in
ChEBI
ChEBI ID
9445
language of work or name
English
title
terazosin
(English)
retrieved
3 October 2016
Freebase ID
/m/07b33v
1 reference
stated in
Freebase Data Dumps
publication date
28 October 2013
Microsoft Academic ID (discontinued)
2776679619
0 references
OpenAlex ID
C2776679619
1 reference
stated in
OpenAlex
retrieved
26 January 2022
reference URL
https://docs.openalex.org/download-snapshot/snapshot-data-format
Römpp online ID
RD-20-00687
1 reference
imported from Wikimedia project
German Wikipedia
UMLS CUI
C0076107
1 reference
stated in
Global Substance Registration System
UNII
8L5014XET7
language of work or name
English
title
terazosin
(English)
retrieved
18 November 2016
WikiProjectMed ID
Terazosin
0 references
WordNet 3.1 Synset ID
04419685-n
1 reference
stated in
GF WordNet
Sitelinks
Wikipedia
(17 entries)
edit
arwiki
تيرازوسين
azbwiki
ترازوسین
cywiki
Terasosin
dewiki
Terazosin
enwiki
Terazosin
eswiki
Terazosina
fawiki
ترازوسین
frwiki
Térazosine
idwiki
Terazosin
itwiki
Terazosina
jawiki
テラゾシン
orwiki
ଟେରାଜୋସିନ
shwiki
Terazosin
srwiki
Terazosin
trwiki
Terazosin
ukwiki
Теразозин
viwiki
Terazosin
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(1 entry)
edit
commonswiki
Category:Terazosin
Retrieved from "
https://www.wikidata.org/w/index.php?title=Q280786&oldid=2427778149
"
Search
Search
terazosin
(Q280786)
Add topic
[8]
ページ先頭
©2009-2026
Movatter.jp
